Camblong Jurgi 4

What Happened

• Camblong Jurgi, CEO of SOPHiA GENETICS SA, sold 4,486 shares on March 19, 2026, in an open-market transaction. The weighted average sale price was $4.77 per share for total proceeds of approximately $21,410. This was a sale (routine cash-out) to satisfy tax obligations tied to the vesting of restricted stock units, not a new buy.

Key Details

• Transaction date: 2026-03-19; Form filed: 2026-03-20 (filed one day after the trade).
• Price reported: weighted average $4.77; sale prices ranged from $4.68 to $4.87 per share.
• Shares sold: 4,486; total proceeds ≈ $21,410.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: (F1) Sales effected to satisfy tax withholding from RSU vesting and executed under a pre-established Rule 10b5-1 trading plan (non-discretionary). (F2) Reported price is a weighted average; detailed per-trade prices available on request as noted in the filing.
• Filing timeliness: The Form 4 was filed the day after the transaction and appears timely under normal reporting rules.

Context

• These sales were executed under a 10b5-1 plan to cover taxes on vested RSUs, which is a common, non-discretionary reason for insider sales and generally less indicative of a change in the insider’s view of the company than discretionary sales or purchases.
• No options exercise or gift activity is reported here — this was a straightforward tax-withholding sale.